Choosing trial sites that are well positioned to support your trial can move it forward faster and on budget. In some cases, it can even be the difference that gets a product to market ahead of competition.
IQVIA's Clinical Operations Suite lets you take an objective, evidence-based approach using search tools and feasibility assessments informed by machine learning, to better analyze site and patient data. The result? The ability to better predict which sites are the best fit with your drug and trial design, and to more easily identify sites at risk for underperformance.
Findings based on IQVIA analysis of more than 10,000 product launches in the top 8 development markets (U.S., Japan, EU5 and Canada) between 2003 and 2016.
From planning through closeout, clinical services have been rigorously tested and improved by sponsors, CROs and sites of all sizes in more than 60 countries.
It's a key reason why 9 of the top 10 pharmaceutical companies, 4 of the top 5 CROs, and the biggest industry collaborations have chosen IQVIA's Clinical Operations Suite. Features include
Activate and engage sites in less time with a suite of clinical operations technologies.
Identifying sites with the right patients and support for your protocol can result in faster start-up. For example, comprehensive, linked patient data can widen the referral net by providing insight on nearby providers with eligible patients.
Data-driven predictive forecasting can enable more precise planning and goal-driven site recruitment. And patient-centric recruitment methods can leverage social and consumer data to inform both messaging and targeting. In combination, data and machine learning can optimize site selection and performance, while giving you a higher level of visibility and control at every decision point.
Get in touch today to discover the right solutions for you.
We are pleased to speak with you during our standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in our toll-free list.